“…Of these 19 study populations, seven assessed the diagnostic performance of gargle in populations with suspected infection [28,49,50,54,55,57,59], and 12 assessed the use of gargle for monitoring viral shedding in populations already confirmed to have SARS-CoV-2 infections, either as hospital inpatients or after being discharged (table 1) [29, 35, 36, 46-48, 51-53, 56, 58, 59]. Regarding the study location, there were five studies from Canada [28,47,50,52,57], six from Germany [36,48,49,51,54,56] and with the rest (seven) from Finland [29], Turkey [55], China [46], Korea [58], Indonesia [59], Israel [53] and India [35]. These studies spanned from 23 March 2020 to 19 July 2021, covering the period of different prevailing SARS-CoV-2 variants, from the ancestral strain, alpha variant, to its delta variant.…”